Clinical Trials Directory

Trials / Unknown

UnknownNCT03238066

Salvage Brachytherapy and Interstitial Hyperthermia for Locally Recurrent Prostate Carcinoma Following Radiation Therapy

A Prospective Phase II Study of Salvage Brachytherapy in Combination With Interstitial Hyperthermia for Locally Recurrent Prostate Carcinoma Following External Beam Radiation Therapy

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
77 (estimated)
Sponsor
University of Erlangen-Nürnberg Medical School · Academic / Other
Sex
Male
Age
18 Years
Healthy volunteers
Not accepted

Summary

Salvage brachytherapy in combination with interstitial hyperthermia for locally recurrent prostate carcinoma following external beam radiation therapy.

Detailed description

Salvage brachytherapy in combination with interstitial hyperthermia for locally recurrent prostate carcinoma following external beam radiation therapy: Salvage brachytherapy: HDRBT: 3 x 10 Gy specified on prostate capsule/tumor margin (d1, 22, 43) or PDRBT: 2 x 30 Gy specified on prostate capsule/tumor margin (d1-3, 29-31) Hyperthermia: prostate heated to 40 - 47˚C for 30-60 minutes (60 minutes recommended) prior to brachytherapy dose delivery. Maximum temperature in surrounding critical normal organs should not exceed 43˚C

Conditions

Interventions

TypeNameDescription
RADIATIONBrachytherapyHDR/PDR brachytherapy
OTHERHyperthermiaInterstitial hyperthermia

Timeline

Start date
2015-04-01
Primary completion
2018-12-01
Completion
2022-04-01
First posted
2017-08-03
Last updated
2018-06-07

Locations

3 sites across 2 countries: Germany, Poland

Source: ClinicalTrials.gov record NCT03238066. Inclusion in this directory is not an endorsement.

Salvage Brachytherapy and Interstitial Hyperthermia for Locally Recurrent Prostate Carcinoma Following Radiation Therapy (NCT03238066) · Clinical Trials Directory